the purpose of such a phase 1 clinical trial is to assess safety , so problems would not come as a total shock . the fact that the trial in cancer patients ( which still needs oks from the food and drug administration , among others ) would be funded by the new cancer institute founded this year by tech mogul sean parker adds a wild card . four potential snafus :